Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sixth Wave Innovations Inc SIXWF

Sixth Wave Innovations Inc. is a Canada-based nanotechnology company with patented technologies. The Company is focused on the extraction and detection of target substances at the molecular level using specialized molecularly imprinted polymers (MIPs). The Company’s product brands include AMIPs, IXOS and Affinity. The IXOS is a line of extraction polymers formulated for deployment in the gold mining industry. The Affinity system is using its MIPs, which are designed to capture and extract cannabinoids from filtered crude extracts without the use of traditional winterization and distillation. The Company’s patent portfolio covers extensions of the designs for extraction and purification of other critical metals including nickel, cobalt, rare earth elements, and platinum group metals. It also designs, develops and commercializes MIP solutions across a spectrum of industries.


GREY:SIXWF - Post by User

Comment by Bvukmanicon Feb 04, 2021 12:09pm
89 Views
Post# 32470897

RE:RE:RE:RE:RE:RE:RE:Go baby go !

RE:RE:RE:RE:RE:RE:RE:Go baby go !Gluckman's comment about existing immunoassay tests potentially being rendered uselss by variants is a bit misleading, these tests can be modified just like MIPS can. Both would require regulatory approval. They aren't the only ones able to develop a MIP to detect a virus either, far from it - and it took too long to develop. If they can validate, obtain regulatory approval (which could take a very long time), and most importantly actually sell enough of them, then they'll have something. A lot has to go right. I'd be more confident if they had guidance from the FDA.

I do like the company, but don't have the stones to give them every penny!
<< Previous
Bullboard Posts
Next >>